Top Markets
Coin of the day
BioDelivery Sciences International, Inc. BioDelivery Sciences International, Inc.

BioDelivery Sciences International, Inc.

BDSI
Rank in Stocks #16145
BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical... BioDelivery Sciences International, Inc. (BDSI) is a specialized pharmaceutical firm dedicated to the advancement and commercialization of therapeutic products designed for long-term health conditions, serving markets both within the United States and internationally. The company's product offerings leverage its proprietary BioErodible MucoAdhesive drug delivery systemβ€”a slender, dissolving polymer film intended for application to the inner cheekβ€”in addition to other drug administration methodologies. Its portfolio includes several key products: BELBUCA, a buprenorphine buccal film, is utilized for the ongoing management of persistent pain. Symproic functions as a peripherally acting mu-opioid receptor antagonist, specifically addressing opioid-induced constipation in adult patients suffering from chronic non-cancer pain. This also covers individuals whose chronic pain is a result of prior cancer or its treatment, provided they do not require frequent increases in opioid dosage. ELYXYB, an oral solution containing celecoxib, provides treatment for adult migraines, irrespective of the presence of an aura. ONSOLIS, a soluble fentanyl film administered buccally, is intended for the management of sudden, severe "breakthrough" pain experienced by cancer patients. Founded in 1997, BioDelivery Sciences International, Inc. is headquartered in Raleigh, North Carolina. As of March 18, 2022, the company operates as a subsidiary of Collegium Pharmaceutical, Inc.
Share Price
$5.59
Last synced: 2022-03-31
Market Cap
$310.83M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade BioDelivery Sciences International, Inc. (BDSI)

Category

Number of shares outstanding for BioDelivery Sciences International, Inc. (BDSI)
Number of shares outstanding as of September 2026: 0
According to BioDelivery Sciences International, Inc. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of September 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for BioDelivery Sciences International, Inc. (BDSI) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors